Mangalam Drugs And Organics Limited — Board Meeting, 14-11-2024: Outcome of Board Meeting

The Board of Directors of Mangalam Drugs and Organics Limited has announced a board meeting to discuss the financial results for the quarter and half-year ended September 30, 2024. The un-audited consolidated results indicate a total income from operations of ₹159.47 crore, alongside total expenses of ₹147.44 crore, leading to a profit before tax of ₹1.18 crore. The balance sheet as of September 30, 2024, shows total assets of ₹364.11 crore, with total equity of ₹147.97 crore. The company continues to focus on strategic growth amidst its ongoing merger plans.